Cargando…

Differential Lyn-dependence of the SHIP1-deficient mast cell phenotype

BACKGROUND: Antigen (Ag)/IgE-mediated mast cell (MC) responses play detrimental roles in allergic diseases. MC activation via the high-affinity receptor for IgE (FcεRI) is controlled by the Src family kinase Lyn. Lyn-deficient (-/-) bone marrow-derived MCs (BMMCs) have been shown by various laborato...

Descripción completa

Detalles Bibliográficos
Autores principales: Nunes de Miranda, Susana M., Wilhelm, Thomas, Huber, Michael, Zorn, Carolin N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4874025/
https://www.ncbi.nlm.nih.gov/pubmed/27206658
http://dx.doi.org/10.1186/s12964-016-0135-0
_version_ 1782432988469919744
author Nunes de Miranda, Susana M.
Wilhelm, Thomas
Huber, Michael
Zorn, Carolin N.
author_facet Nunes de Miranda, Susana M.
Wilhelm, Thomas
Huber, Michael
Zorn, Carolin N.
author_sort Nunes de Miranda, Susana M.
collection PubMed
description BACKGROUND: Antigen (Ag)/IgE-mediated mast cell (MC) responses play detrimental roles in allergic diseases. MC activation via the high-affinity receptor for IgE (FcεRI) is controlled by the Src family kinase Lyn. Lyn-deficient (-/-) bone marrow-derived MCs (BMMCs) have been shown by various laboratories to exert stronger activation of the PI3K pathway, degranulation, and production of pro-inflammatory cytokines compared to wild-type (wt) cells. This mimics the phenotype of BMMCs deficient for the SH2-containing inositol-5’-phosphatase 1 (SHIP1). In this line, Lyn has been demonstrated to tyrosine-phosphorylate and activate SHIP1, thereby constituting a negative feedback control of PI3K-mediated signals. However, several groups have also reported on Lyn-/- BMMCs degranulating weaker than wt BMMCs. RESULTS: Lyn-/- BMMCs, which show a suppressed degranulation response, were found to exhibit abrogated tyrosine phosphorylation of SHIP1 as well. This indicated that even in the presence of reduced SHIP1 function MC degranulation is dependent on Lyn function. In contrast to the reduced immediate secretory response, pro-inflammatory cytokine production was augmented in Lyn-/- BMMCs. For closer analysis, Lyn/SHIP1-double-deficient (dko) BMMCs were generated. In support of the dominance of Lyn deficiency, dko BMMCs degranulated significantly weaker than SHIP1-/- BMMCs. This coincided with reduced LAT1 and PLC-γ1 phosphorylation as well as Ca(2+) mobilization in those cells. Interestingly, activation of the NFκB pathway followed the same pattern as measured by IκBα phosphorylation/degradation as well as induction of NFκB target genes. This suggested that Ag-triggered NFκB activation involves a Ca(2+)-dependent step. Indeed, IκBα phosphorylation/degradation and NFκB target gene induction were controlled by the Ca(2+)-dependent phosphatase calcineurin. CONCLUSIONS: Lyn deficiency is dominant over SHIP1 deficiency in MCs with respect to Ag-triggered degranulation and preceding signaling events. Moreover, the NFκB pathway and respective targets are activated in a Lyn- and Ca(2+)-dependent manner, reinforcing the importance of Lyn for MC activation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12964-016-0135-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4874025
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-48740252016-05-21 Differential Lyn-dependence of the SHIP1-deficient mast cell phenotype Nunes de Miranda, Susana M. Wilhelm, Thomas Huber, Michael Zorn, Carolin N. Cell Commun Signal Research BACKGROUND: Antigen (Ag)/IgE-mediated mast cell (MC) responses play detrimental roles in allergic diseases. MC activation via the high-affinity receptor for IgE (FcεRI) is controlled by the Src family kinase Lyn. Lyn-deficient (-/-) bone marrow-derived MCs (BMMCs) have been shown by various laboratories to exert stronger activation of the PI3K pathway, degranulation, and production of pro-inflammatory cytokines compared to wild-type (wt) cells. This mimics the phenotype of BMMCs deficient for the SH2-containing inositol-5’-phosphatase 1 (SHIP1). In this line, Lyn has been demonstrated to tyrosine-phosphorylate and activate SHIP1, thereby constituting a negative feedback control of PI3K-mediated signals. However, several groups have also reported on Lyn-/- BMMCs degranulating weaker than wt BMMCs. RESULTS: Lyn-/- BMMCs, which show a suppressed degranulation response, were found to exhibit abrogated tyrosine phosphorylation of SHIP1 as well. This indicated that even in the presence of reduced SHIP1 function MC degranulation is dependent on Lyn function. In contrast to the reduced immediate secretory response, pro-inflammatory cytokine production was augmented in Lyn-/- BMMCs. For closer analysis, Lyn/SHIP1-double-deficient (dko) BMMCs were generated. In support of the dominance of Lyn deficiency, dko BMMCs degranulated significantly weaker than SHIP1-/- BMMCs. This coincided with reduced LAT1 and PLC-γ1 phosphorylation as well as Ca(2+) mobilization in those cells. Interestingly, activation of the NFκB pathway followed the same pattern as measured by IκBα phosphorylation/degradation as well as induction of NFκB target genes. This suggested that Ag-triggered NFκB activation involves a Ca(2+)-dependent step. Indeed, IκBα phosphorylation/degradation and NFκB target gene induction were controlled by the Ca(2+)-dependent phosphatase calcineurin. CONCLUSIONS: Lyn deficiency is dominant over SHIP1 deficiency in MCs with respect to Ag-triggered degranulation and preceding signaling events. Moreover, the NFκB pathway and respective targets are activated in a Lyn- and Ca(2+)-dependent manner, reinforcing the importance of Lyn for MC activation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12964-016-0135-0) contains supplementary material, which is available to authorized users. BioMed Central 2016-05-20 /pmc/articles/PMC4874025/ /pubmed/27206658 http://dx.doi.org/10.1186/s12964-016-0135-0 Text en © Nunes de Miranda et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Nunes de Miranda, Susana M.
Wilhelm, Thomas
Huber, Michael
Zorn, Carolin N.
Differential Lyn-dependence of the SHIP1-deficient mast cell phenotype
title Differential Lyn-dependence of the SHIP1-deficient mast cell phenotype
title_full Differential Lyn-dependence of the SHIP1-deficient mast cell phenotype
title_fullStr Differential Lyn-dependence of the SHIP1-deficient mast cell phenotype
title_full_unstemmed Differential Lyn-dependence of the SHIP1-deficient mast cell phenotype
title_short Differential Lyn-dependence of the SHIP1-deficient mast cell phenotype
title_sort differential lyn-dependence of the ship1-deficient mast cell phenotype
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4874025/
https://www.ncbi.nlm.nih.gov/pubmed/27206658
http://dx.doi.org/10.1186/s12964-016-0135-0
work_keys_str_mv AT nunesdemirandasusanam differentiallyndependenceoftheship1deficientmastcellphenotype
AT wilhelmthomas differentiallyndependenceoftheship1deficientmastcellphenotype
AT hubermichael differentiallyndependenceoftheship1deficientmastcellphenotype
AT zorncarolinn differentiallyndependenceoftheship1deficientmastcellphenotype